Skip to main content
. Author manuscript; available in PMC: 2009 Sep 25.
Published in final edited form as: Clin Pharmacol Ther. 2007 Sep 19;83(1):160–166. doi: 10.1038/sj.clpt.6100367

Figure 3.

Figure 3

Kaplan–Meier estimates of RFS based on metabolizer status (extensive, intermediate, or poor). Reprinted with permission from Goetz, M.P. et al. Breast Cancer Res. Treat. 101, 113–121 (2007).